A Common Laxative Improved Memory Scores In People Who’ve Had Depression

Depression Can Leave the Mind Foggy Long After It Clears. A Constipation Drug May Help

For the millions of people who’ve battled depression, getting better doesn’t always mean getting back to normal. Even after the sadness lifts, the brain fog often lingers: the forgetfulness, the sluggish thinking, the frustrating sense that the mind just isn’t as sharp as it once was. Now, a small study suggests that a drug already on pharmacy shelves for a completely different reason might help fix that.

Researchers gave participants with a history of depression a drug called prucalopride, a medication used to treat chronic constipation, for about a week. The result was measurable improvements in memory and thinking speed on specific cognitive tests, with no changes to mood, suggesting the drug may be doing something useful in the brain that has nothing to do with its original purpose.

Depression affects tens of millions of Americans, and the cognitive toll it takes is often overlooked. Thinking and memory problems are common during depressive episodes, and many people say those difficulties persist even after other symptoms resolve. Standard antidepressants don’t do much to fix that. This study tested whether targeting a particular brain receptor that prucalopride activates could help fill that gap.

Prucalopride Was Tested Against Placebo in Adults Who Had Recovered From Depression

Researchers enrolled 50 participants between ages 18 and 40 who were not currently depressed but had experienced at least two previous episodes of major depression. None were taking psychiatric medications at the time. Participants were randomly assigned to receive either prucalopride or a placebo for about a week, with neither group nor researchers knowing who was getting what. Prucalopride was started at a lower dose for the first two days, then increased to 2mg daily for the remainder.

Before and after the medication period, participants completed a range of thinking and memory tests: word recall, a memory speed task, processing speed, mental flexibility, and tasks involving emotional information like identifying facial expressions. That range let researchers see not just whether the drug helped with general thinking, but whether any improvement was tied to emotional content specifically.

Memory and Thinking Scores Rose Across Multiple Tests

On the word recall test, where participants heard a list of 15 words read aloud and were asked to repeat back as many as possible, the prucalopride group outperformed the placebo group across multiple rounds, even after accounting for baseline performance. No significant difference appeared in delayed recall, meaning the advantage was in active learning rather than retention over time.

On the memory speed task, which requires holding information in mind while tracking new information, the prucalopride group responded significantly faster than those on placebo without sacrificing accuracy. In cognitive testing, going faster often just means becoming sloppier. Participants taking prucalopride avoided that trade-off.

Participants on the drug also did better at identifying fleeting facial expressions. Images of faces showing emotions like fear, happiness, anger, or surprise were flashed on screen for just half a second, and the prucalopride group correctly identified more of them across all emotions, suggesting a general sharpening of perception rather than a shift in emotional sensitivity.

Tasks designed to probe emotional biases, the kinds of changes typically seen with traditional antidepressants, showed no meaningful differences between the two groups. Across the board, the cognitive improvements in the prucalopride group couldn’t be explained by baseline mood or self-reported thinking difficulties.

Prucalopride Targets a Brain Receptor Tied to Learning and Memory

Prucalopride works by activating serotonin-4 receptors found in the hippocampus, a brain region central to learning and memory, as well as in other brain areas. Serotonin is a chemical messenger most people know from its connection to mood, but this particular receptor appears to have a more direct line to how the brain processes and retains new information.

Earlier animal studies showed that activating this receptor improved learning and memory. Prior work in healthy volunteers also found that prucalopride boosted memory performance, giving researchers enough confidence to try it in people with a depression history. In that group, cognitive improvements held up, though further studies in larger, more diverse populations are needed to confirm them.

Researchers also note an emerging gut-brain angle: the vast majority of the body’s serotonin is produced in the gut, and these same receptors may play a role in how signals travel between the gut and brain, potentially explaining how this drug produces its effects.

Post-Depression Brain Fog Still Has No Approved Treatment

For people who’ve cycled through depression and come out the other side but still feel mentally slower than they used to, there are currently no approved treatments aimed at that specific problem. This study, published in Psychological Medicine, doesn’t solve that yet. It’s small, short, and the participant group was predominantly female, white, and highly educated, which limits how broadly the findings apply.

A drug with an existing safety track record that targets a brain system with a well-studied connection to memory produced improved scores on specific cognitive tests in just a week. Whether follow-up studies confirm these results remains to be seen. If they do, prucalopride could offer one possible approach to the cognitive difficulties that can linger long after mood has recovered, a gap that current depression treatment has not reliably addressed.

---

Disclaimer: This article is not intended to provide medical advice. If you have questions or concerns about depression treatment or any medication, consult a qualified healthcare provider.

---